Valuation Dr. Reddy's Laboratories Limited NYSE

Stocks

Market Closed - NYSE 16:00:02 2026-10-07 EDT			5-day change	1st Jan Change
12.27 ^USD	-1.76%		-4.51%	-12.61%

10-07	Asian Equities Traded in the US as American Depositary Receipts Tumble in Wednesday Trading	MT
10-06	Asian Equities Traded in the US as American Depositary Receipts Edge Lower in Tuesday Trading	MT

Data adjusted to current consolidation scope

Fiscal Period: March	2022	2023	2024	2025	2026	2027	2028	2029
Market Cap ¹	714,500	767,655	1,024,969	953,168	1,044,616	1,001,580	-	-
Change	-	7.44%	33.52%	-7.01%	9.59%	-4.12%	-	-
Enterprise Value (EV) ¹	703,980	719,330	960,383	928,633	1,011,902	969,645	950,158	920,690
Change	-	2.18%	33.51%	-3.31%	8.97%	-4.18%	-2.01%	-3.1%
P/E	30.4x	17.1x	18.4x	16.9x	24.4x	27.2x	20.8x	17.3x
PBR	3.76x	3.33x	3.63x	2.86x	2.78x	2.46x	2.23x	2.02x
PEG	-	0.2x	0.8x	13.12x	-1x	-2x	0.7x	0.8x
Capitalization / Revenue	3.33x	3.11x	3.67x	2.93x	3.11x	2.85x	2.55x	2.31x
EV / Revenue	3.28x	2.92x	3.44x	2.85x	3.01x	2.76x	2.42x	2.12x
EV / EBITDA	13.7x	11.1x	12.1x	10.8x	15.1x	15.7x	12x	10x
EV / EBIT	20.5x	13.8x	14.8x	13.4x	21.8x	23.8x	17x	13.6x
EV / FCF	52.3x	15.1x	33.1x	49.1x	30.3x	24.5x	26.2x	18.9x
FCF Yield	1.91%	6.61%	3.02%	2.04%	3.3%	4.09%	3.82%	5.28%
Dividend per Share ²	6	8	8	8	8	7.575	8.413	9.097
Rate of return	0.7%	0.87%	0.65%	0.7%	0.64%	0.63%	0.7%	0.76%
EPS ²	28.34	54.18	66.92	67.78	51.42	44.28	57.68	69.64
Distribution rate	21.2%	14.8%	12%	11.8%	15.6%	17.1%	14.6%	13.1%
Net sales ¹	214,391	246,697	279,164	325,535	335,933	351,901	393,150	433,791
EBITDA ¹	51,400	64,559	79,481	86,236	67,048	61,834	79,439	91,852
EBIT ¹	34,277	52,057	64,781	69,178	46,443	40,754	55,795	67,870
Net income ¹	23,568	45,073	55,779	56,544	42,850	36,589	48,561	58,098
Net Debt ¹	-10,520	-48,325	-64,586	-24,535	-32,714	-31,935	-51,422	-80,890
Reference price ²	861.08	924.30	1,231.03	1,144.05	1,254.65	1,202.40	1,202.40	1,202.40
Nbr of stocks (in thousands)	829,771	830,526	832,611	833,152	832,596	832,984	-	-
Announcement Date	5/19/22	5/10/23	5/7/24	5/9/25	5/12/26	-	-	-

¹INR in Million²INR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
ELI LILLY AND COMPANY	32.87x	11.93x	24.1x	0.6%	1,032B
JOHNSON & JOHNSON	28.34x	6.29x	17.98x	2.1%	614B
ABBVIE INC.	37.73x	7.89x	16.32x	2.6%	471B
MERCK & CO., INC.	103.26x	5.79x	24.59x	2.4%	350B
ROCHE HOLDING AG	19.01x	4.63x	11.48x	2.86%	337B
NOVARTIS AG	19.87x	5.19x	12.84x	3.07%	268B
ASTRAZENECA PLC	20.52x	4.22x	12.02x	2.1%	246B
AMGEN INC.	25.43x	6.65x	11.85x	2.51%	218B
GILEAD SCIENCES, INC.	-43.62x	6.37x	24.89x	2.28%	179B
Average	27.04x	6.55x	17.34x	2.28%	412.76B
Weighted average by Cap.	32.24x	7.67x	18.71x	1.95%